LONA
LeonaBio, Inc.
NASDAQ: LONA · HEALTHCARE · BIOTECHNOLOGY
$9.10
+3.76% today
Updated 2026-04-30
Market cap
$78.44M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-24.70
Dividend yield
—
52W range
$2 – $14
Volume
0.1M
LeonaBio, Inc. (LONA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-290.80%
ROA
-28.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | — | $-5.10M | — | — | — |
| 2019 | — | $-5.16M | — | — | — |
| 2020 | — | $-19.95M | — | — | — |
| 2021 | $0.00 | $-54.85M | — | — | — |
| 2022 | $0.00 | $-95.64M | — | — | — |
| 2023 | $0.00 | $-117.67M | — | — | — |
| 2024 | $0.00 | $-96.94M | — | — | — |
| 2025 | $0.00 | $-105.61M | — | — | — |